Here, we present data showing that this assay simultaneously detected and quantified mRNA levels of three tumor associated antigens (TAAs) as a ratio to a homeostatic ABL1 in the peripheral blood and preliminary data of ability of this test to detect MRD in relapsed acute leukemia after HCT in the peripheral blood. This evidence concerns the gene ABL1 and acute leukemia.